Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

November 9, 2020

Study Completion Date

December 17, 2021

Conditions
NASH (Non-Alcoholic Steatohepatitis)
Interventions
DRUG

Vitamin E softgel

All participants receive standardized recommendations for life-style modification (Diet modification, weight loss, exercise).

DRUG

Placebo

"All participants receive standardized recommendations for life-style modification (Diet modification, weight loss, exercise).~Height and weight, waist-to-hip ratio Review of diet and exercise"

Trial Locations (15)

Unknown

Beijing Ditan Hospital Capital Medical University, Beijin

302 Military Hospital of China, Beijing

Beijing YouAn Hospital Capital Medical Univercity, Beijing

West China Hospital, Sichuan university, Chengdu

The first Affiliated Hospital, Sun Yat-sen University, Guangdong

Guangdong Provincial Chinese Medicine Hospital, Guangzhou

Nanfang Hospital, Guangzhou

The Affiliated Hospital of Hangzhou Normal University, Hangzhou

Southwest Medical University Affiliated, Luzhou

The Second Hospital of Nanjing, Nanjing

The First Hospital of China Medical University, Shenyang

The second people's Hospital of Tianjin, Tianjin

The First Affiliated Hospital of Medical University, Ürümqi

The First Affiliated Hospital of Wenzhou Medical University, Wenzhu

General Hospital Ningxia Medical, Yinchuan

All Listed Sponsors
collaborator

R&G Pharma Studies Co.,Ltd.

INDUSTRY

collaborator

The Affiliated Hospital of Hangzhou Normal University

OTHER

lead

Zhejiang Medicine Co., Ltd.

INDUSTRY

NCT02962297 - Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter